PGEN
Precigen, Inc. · Healthcare · Biotechnology
At close
$3.84
+$0.04 (+1.19%) Close
Pre-market $3.84 +$0.00 (+0.13%) 6:17 PM ET
Prev close $3.79
Open $3.84
Day high $3.84
Day low $3.84
Volume 510
Avg vol 4,266,706
Mkt cap
$1.34B
P/E ratio
-2.76
FY Revenue
$6.31M
EPS
-1.39
Gross Margin
30.32%
Sector
Healthcare
AI report sections
PGEN
Precigen, Inc.
Precigen’s share price has delivered very large 6- and 12-month gains but is now consolidating below short-term moving averages with mixed momentum signals. Fundamentally, the company shows very small revenue relative to market cap, deeply negative margins, and heavy cash burn, partially offset by solid revenue growth and a current-asset-heavy balance sheet. Short interest is elevated with a high days-to-cover figure, while recent news flow has been positively skewed around clinical and regulatory milestones, creating a backdrop of both opportunity and execution risk.
AI summarized at 4:15 PM ET, 2025-12-12
AI summary scores
INTRADAY: 48 SWING: 55 LONG: 34
Volume vs average
Intraday (cumulative)
−35% (Below avg)
Vol/Avg: 0.65×
RSI
37.11 (Weak)
Weak (30–40)
MACD momentum
Intraday
+0.00 (Strong)
MACD: 0.01 Signal: 0.00
Short-Term
-0.13 (Weak)
MACD: -0.11 Signal: 0.02
Long-Term
-0.11 (Weak)
MACD: 0.06 Signal: 0.17
Intraday trend score 28.91

Latest news

PGEN 12 articles Positive: 3 Neutral: 0 Negative: 0
Positive The Motley Fool • Cory Renauer
Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares

Patient Capital Management increased its stake in Precigen by 10.2 million shares in Q3 2025, valuing the transaction at approximately $28.78 million. The investment represents 3.48% of the fund's assets under management, following Precigen's significant stock price surge after FDA approval of Papzimeos.

PGEN C CPN AMZN gene therapy biotechnology investment FDA approval
Sentiment note

Stock up 375.91% over past year, received FDA full approval for Papzimeos, and attracted significant institutional investment from Patient Capital Management

Positive The Motley Fool • Cory Renauer
These 2 Healthcare Stocks More Than Doubled Recently and Could Soar Higher, According to Wall Street Analysts

Two healthcare stocks, Precigen and Mineralys Therapeutics, have seen significant stock price increases recently due to FDA approval and promising clinical trial results in rare disease treatment and hypertension medication development.

PGEN MLYS AZN healthcare stocks FDA approval hypertension clinical trials
Sentiment note

FDA approved Papzimeos for rare respiratory disease, with potential peak annual sales over $1 billion and analysts recommending a buy rating

Positive Benzinga • Lekha Gupta
Precigen Soars: Biologics License Application Submission For PRGN-2012 Targets First FDA-Approved Recurrent Respiratory Papillomatosis Treatment

Precigen has submitted a biologics license application to the FDA for PRGN-2012, a potential first treatment for recurrent respiratory papillomatosis. The submission is a significant step forward, as PRGN-2012 has received Breakthrough Therapy and Orphan Drug Designations from the FDA.

PGEN Precigen PRGN-2012 recurrent respiratory papillomatosis FDA Breakthrough Therapy Designation Orphan Drug Designation
Sentiment note

The article highlights Precigen's progress in submitting a biologics license application for PRGN-2012, a potential first treatment for a rare and life-threatening condition. This is a significant milestone for the company, as the therapy has received important designations from the FDA, indicating its potential to address an unmet medical need.

Unknown Benzinga • Benzinga Insights
6 Analysts Assess Precigen: What You Need To Know

Precigen (NASDAQ:PGEN) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 5 1 0 0 0 Last 30D 2 0 0 0 0 1M Ago 2 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 0 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $8.17, a high estimate of $14.00, and a low estimate of $6.00. This current average has increased by 29.07% from the previous average price target of $6.33. Investigating Analyst Ratings: An Elaborate Study The analysis of recent analyst actions sheds light on the perception of Precigen by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Swayampakula Ramakanth HC Wainwright & Co. Maintains Buy $6.00 $6.00 Benjamin Burnett Stifel Raises Buy $10.00 $7.00 Swayampakula Ramakanth HC Wainwright & Co. Maintains Buy $6.00 $6.00 Benjamin Burnett Stifel Maintains Buy $7.00 - Jason Butler JMP Securities Maintains Market Outperform $14.00 - Swayampakula Ramakanth HC Wainwright & Co. Maintains Buy $6.00 - Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Precigen. This information offers a ...Full story available on Benzinga.com

PGEN Analyst Ratings
Unknown Seeking Alpha • Wall Street Breakfast
Wall Street Breakfast: The Week Ahead

Read about the upcoming Wall Street events, earnings reports, conferences, and IPOs for the week ahead.

HPE LULU NIO WMT
Unknown Zacks Investment Research • Zacks Equity Research
Precigen, Inc. (PGEN) Reports Q1 Loss, Misses Revenue Estimates

Precigen (PGEN) delivered earnings and revenue surprises of -11.11% and 30.84%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

PGEN MYNZ
Unknown Zacks Investment Research • Zacks Equity Research
Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates

Allogene Therapeutics (ALLO) delivered earnings and revenue surprises of 0% and 47.62%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

ALLO PGEN
Unknown Benzinga • Avi Kapoor
Why FactSet Research Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected second-quarter revenue and issued FY24 guidance. FactSet Research posted adjusted earnings of $4.22 per share, beating market estimates of $3.88 per share. The company’s quarterly sales came in at $545.95 million, missing expectations of $546.80 million, according to data from Benzinga Pro. FactSet Research shares dipped 5.2% to $462.36 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares jumped 136.7% to $0.5751 after the company announced that the USDA-APHIS Biotechnology Regulatory Services determined that the Camelina sativa varieties may be planted and bred in the United States. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares jumped 101.7% to $2.6850 after falling 11% on Wednesday. CuriosityStream Inc. (NASDAQ: CURI) rose 63.2% to $2.6850 after the company reported financial results for fourth quarter. Portage Biotech Inc. (NASDAQ: PRTG) gained 53.7% to $0.7525. Lufax Holding Ltd (NYSE: LU) climbed 41.3% to $4.76 following fourth-quarter results. Asset Entities Inc. (NASDAQ: ASST) shares climbed 37% to $0.7173 after the company announced that it entered into an agreement with Zendrop. Cazoo Group Ltd (NYSE: CZOO) gained 33% to $4.6475. Guess?, Inc. (NYSE: GES) shares rose 23.1% to $31.95 as the company reported better-than-expected fourth-quarter financial results and declared a special dividend of $2.25 per share. Nortech Systems Incorporated (NASDAQ: NSYS) surged 22.3% to $13.35 after the company reported fourth-quarter results. JOANN Inc. (NASDAQ: JOAN) gained 20.8% to $0.1631. Aemetis, Inc. (NASDAQ: AMTX) climbed 18.4% to $4.3238 after the company announced approval by the U.S. Citizenship and Immigration Services for a $200 million of EB-5 program investment for the Riverbank sustainable aviation fuel, production plant, the dairy renewable natural gas project, the ...

LU ALAB AMTX LXEH News Penny Stocks Small Cap Intraday Update
Unknown Benzinga • Avi Kapoor
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. (NASDAQ: MNDY) fell sharply in today’s pre-market trading after the company reported fourth-quarter financial results. Monday.com posted adjusted earnings of 65 cents per share on sales of $202.57 million. monday.com shares dipped 9% to $214.69 in pre-market trading. Here are some big stocks recording losses in today’s pre-market trading session. AN2 Therapeutics, Inc. (NASDAQ: ANTX) shares dipped 72% to $5.59 in pre-market trading as the company said it will voluntarily pause ...

WYNN MANU APLD ANTX News Penny Stocks Small Cap Pre-Market Outlook
Unknown Benzinga • Avi Kapoor
Why Amtech Systems Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) rose sharply in today’s pre-market trading after the company reported upbeat results for its first quarter on Friday. Amtech Systems posted an adjusted loss of 4 cents per share, compared to market estimates for a loss of 26 cents per share. The company’s quarterly sales came in at $24.92 million topping expectations of $22.25 million, according to data from Benzinga Pro. Amtech Systems shares surged 7.6% to $3.70 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Millennium Group International Holdings Limited (NASDAQ: MGIH) gained 142.7% to $2.50 in pre-market trading. YC 1926 (BVI) Limited reported an 88.89% stake in a 13G filing on Friday. DIH Holdings US, Inc. (NASDAQ: DHAI) gained 94% to $2.51 in pre-market trading. DIH Holding US secured $1.5 million in private placement financing from OrbiMed. SuperCom Ltd. (NASDAQ: SPCB) shares jumped 52.6% to $0.2802 in pre-market trading. SuperCom recently disclosed that it has secured a new contract with an established California services provider in the judicial sector. SeaStar Medical Holding Corporation (NASDAQ: ICU) ...

WLDS LUNR ASYS HOLO News Penny Stocks Small Cap Pre-Market Outlook
Unknown Benzinga • Avi Kapoor
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) rose sharply during Tuesday’s session after the company released topline data from the PACIFIC Phase 1b/2a study evaluating bexicaserin (LP352) for seizures associated with a broad range of Developmental and Epileptic Encephalopathies (DEEs). Longboard Pharmaceuticals shares jumped 199.7% to $18.07 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Akso Health Group (NASDAQ: AHG) surged 85% to $1.2946. Polished.com Inc. (NYSE: POL) gained 45% to $8.77. Dogness (International) Corporation (NASDAQ: DOGZ) jumped 40% to $7.42. Cue Health Inc. (NASDAQ: HLTH) gained 36.8% to $0.2224 after falling 42% on Friday. Voyager Therapeutics, Inc. (NASDAQ: VYGR) surged 34% to $11.38 after the company announced a strategic collaboration and capsid license agreement with Novartis to advance potential gene therapies for Huntington's disease and spinal muscular atrophy. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 33.5% to $0.4450 after gaining around 17% on Friday. RiskOn International recently said it expects to announce its new generative AI platform and unveil a principal technology partner on Jan. 3. Soligenix, Inc. (NASDAQ: SNGX) shares gained 33.4% to $1.01. Soligenix announced publication demonstrating complete protection against filovirus disease in nonhuman primate models of ebola and marburg viruses. SenesTech, Inc. (NASDAQ: SNES) gained 22.2% to $1.56. SenesTech announced the expansion of its distribution agreement with Pesterminators Pvt Ltd to include the deployment of EvolveTM. Brooge Energy Limited (NASDAQ: BROG) jumped 17.1% to $4.31. Brooge Energy recently announced that it reached a settlement with the SEC where it agreed to pay a $5 million penalty and cease any future violations. Lyell Immunopharma, Inc. (NASDAQ: LYEL) gained 16.9% to $2.26. Wheels Up Experience Inc. (NYSE:

MARA BROG MOBX BTCS News Penny Stocks Small Cap Intraday Update
Unknown Benzinga • Lisa Levin
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Wynn Resorts reported third quarter operating revenue of $1.67 billion, which was up from a total of $889.7 million reported in the prior year's period. The revenue total beat a Street consensus estimate of $1.585 billion. The company reported adjusted earnings per share of 99 cents, which beat a Street consensus estimate of 75 cents per share. Wynn Resorts shares declined 8.1% to $83.29 on Friday. Here are some other stocks moving in today’s mid-day session. Gainers INVO Bioscience, Inc. (NASDAQ: INVO) shares jumped 112% to $1.49. NAYA Biosciences and INVO Bioscience named Dr. Peter Kash, Ed.D., MBA as Vice Chairman following closing of their pending merger. Marpai, Inc. (NASDAQ: MRAI) shares climbed 76% to $0.6740 after the company filed to withdraw the registration statement on Form S-1. The company confirmed no securities have been sold in connection with the offering contemplated by the Registration Statement. TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) shares gained 56.2% to $0.2499 after the company reported third-quarter financial results. GlucoTrack, Inc. (NASDAQ: GCTK) rose 47% to $0.2371. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 43% to $3.7250 trading after the company reported better-than-expected third-quarter financial results. Synchronoss Technologies, Inc. (NASDAQ: SNCR) rose 28.6% to $0.4479. The company recently reported third-quarter results. Blink Charging Co. (NASDAQ: BLNK) climbed 26.4% to $3.1100 after the company reported strong third-quarter revenue and raised 2023 revenue target. Ouster, Inc. (NYSE: OUST) gained 24.8% to $5.14 following upbeat quarterly results. VIZIO Holding Corp. (NYSE: VZIO) rose 22.4% to $6.46 after the company reported third-quarter financial results. Yoshitsu Co., Ltd (NASDAQ: TKLF) gained 20.9% to $0.62. Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) jumped 20.5% to $1.35. Sunrise New Energy Chairman announced purchase of 200,000 shares in 30 days. Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares gained 19.6% to $0.5226 after jumping over 92% on Thursday. The company reported first-quarter financial results on Wednesday. AVITA Medical, Inc. (NASDAQ: RCEL) climbed 18.3% to $11.70 after the company reported better-than-expected third-quarter sales. The Joint Corp. (NASDAQ: JYNT) climbed 17.5% to $8.66 following upbeat sales. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) gained 17.4% to $1.0683. Nemaura Medical Inc. (NASDAQ: NMRD) rose 17.4% to $0.27. Virios Therapeutics, Inc. ...

MPW CDIO EVA TSHA News Penny Stocks Small Cap Intraday Update
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal